As part of our commitment to supporting your laboratory's research and diagnostic efforts, take a look at our most recent additions to the Seraseq® product portfolio.
Designed to meet the diverse needs of clinical labs performing cutting-edge NGS assays.
ORDER NOW
Oncology
- Seraseq® ctDNA Prostate Mix WT
- Seraseq® ctDNA Prostate Mix AF1%
- Seraseq® ctDNA Prostate Mix AF0.5%
- Seraseq® ctDNA Mutation Mix v4 AF0.1%
- Seraseq® ctDNA Mutation Mix v4 AF0.5%
- Seraseq® ctDNA Mutation Mix v4 AF5%
- Seraseq® ctDNA Mutation Mix v4 WT
- Seraseq® ctDNA ESR1 Mutation Mix AF1%
- Seraseq® ctDNA ESR1 Mix WT
- Seraseq® ctDNA Extraction Reference Material 20 ng/mL
- Seraseq® ctDNA Extraction Reference Material 50 ng/mL
- Seraseq® ctDNA Extraction Reference Material 80 ng/mL
- Seraseq® Methylated ctDNA Mix
- Seraseq® Unmethylated ctDNA Mix
- Seraseq® ctDNA Lymphoma Mix WT
- Seraseq® ctDNA Lymphoma Mix AF 1%
- Seraseq® ctDNA Lymphoma Mix AF 0.5%
- Seraseq® ctDNA Lymphoma Mix AF 0.1%
- Seraseq® HRD gDNA Low-Positive Mix
- Seraseq® HRD gDNA High-Positive Mix
- Seraseq® HRD gDNA Negative Mix
- Seraseq® gDNA CNV Mutation Mix
- Seraseq® gDNA BRCA1/2 LGR Somatic Mutation Mix
- Seraseq® FFPE BRCA 1/2 LGR Reference Material
- Seraseq® FFPE Solid Tumor CNV
- Seraseq® FFPE HRD High-positive, Low-Positive, Negative
- Seraseq® ctDNA Myeloid Mutation Mix
- Seraseq® gDNA TMB Reference Panel Mix
ORDER NOW
Genomic Health
